文献速递中枢神经肿瘤放疗

预测靶区勾画变异对危及器官剂量的影响:一项定性调查研究

Predicting the impact of target volume contouring variations on the organ at risk dose: results of a qualitative survey.
PubMed 文献 · Radiother Oncol · 2025-06-26

该定性调查纳入4名放射肿瘤科医生和3名医学物理师,对14例胶质母细胞瘤患者的54个靶区勾画变异评估其对危及器官剂量的影响。评估者间一致性为弱至中等(Cohen's Kappa 0.33-0.74),常高估变异的负面影响,将46%的「无变化」变异误判为「更差」。无评估者判断变异可改善危及器官剂量,而实际有4个变异如此。

要点

  • 评估者间一致性弱至中等(Cohen's Kappa 0.33-0.74)。
  • 46%的「无变化」变异被误判为「更差」。
  • 无评估者识别出可改善危及器官剂量的变异。

核心结论

  • 评估靶区勾画变异对危及器官剂量影响时存在显著评估者间变异,亟需标准化指南。
  • 评估者常高估变异的负面影响,可能导致临床效率下降和不必要的勾画修正。

研究设计与样本

  • 定性调查研究,纳入4名放射肿瘤科医生和3名医学物理师。
  • 14例胶质母细胞瘤患者共54个靶区勾画变异,每个变异最多涉及4处修改。
  • 评估者将变异对危及器官剂量的预期影响分类为「更好」「无变化」或「更差」。
  • 真实标签由标准化治疗计划推导,评估者间变异采用Cohen's Kappa分析。

主要发现

  • Cohen's Kappa值范围为0.33-0.74,一致性弱至中等。
  • 评估者将46%的「无变化」变异误判为「更差」。
  • 无评估者判断任何变异导致危及器官剂量「更好」,而实际有4个变异如此。

临床怎么用

  • 临床评估自动勾画变异时需警惕高估负面影响倾向,避免不必要的修正。
  • 建议基于临床有意义因素评估自动生成轮廓,并制定标准化指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Integrating auto-contouring in radiotherapy workflows is shifting the role of radiation oncologists from manual delineation to reviewing and correcting automatically generated contours. However, we postulate that this process is hindered by significant inter-evaluator variability in assessing the dosimetric impact of contour variations. This study investigates how radiation oncologists and medical physicists evaluate the impact of glioblastoma target volume (TV) variations on the dose to organs at risk (OARs), focusing on understanding inter-evaluator variability and decision-making patterns. METHODS: A qualitative survey was conducted involving four radiation oncologists and three medical physicists. Participants classified 54 glioblastoma TV contour variations using up to four changes each across 14 patients as "better," "no change," or "worse" regarding their expected impact on the dose to OARs. The corresponding ground truth labels were derived from standardized treatment plans. Inter-evaluator variability was analyzed using Cohen's Kappa. RESULTS: Substantial variability was observed, with Cohen's Kappa values ranging from weak to moderate agreement (0.33-0.74). Evaluators frequently overestimated the negative impact of contour variations, misclassifying 46% of "no change" variations as "Worse." No evaluator judged contour variations as resulting in "better" doses to OARs, despite this being the case for 4 variations. CONCLUSION: Significant variability in estimating the dosimetric impact of contour variations underscores the critical need for standardized guidelines to reduce inconsistencies and allow for the assessment of automatically generated contours based on clinically meaningful factors. Evaluators frequently overestimated the negative impact of contour variations, potentially leading to inefficiencies and unnecessary contour corrections in clinical practice.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Willmann J, Kamath A, Poel R, et al. Predicting the impact of target volume contouring variations on the organ at risk dose: results of a qualitative survey. Radiother Oncol. 2025. PMID: 40581214. doi:10.1016/j.radonc.2025.110999

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。